Furthermore, putting the data together with data from Figures 3E, 5, it suggests that the rIL33/PNE was sufficient to sensitize for oral PNE-induced anaphylaxis through a combined pathway of IL33 and PNE-stimulated Areg. The gene discussed is IL33; the disease is anaphylaxis.